Neurocrine Biosciences | 株式

Stock 変化する 日付
AbbVie USD 3.98B 74M 2023-09
Acadia Pharmaceuticals USD 35.82M 15.05M 2023-12
Agios Pharmaceuticals USD 8.49M 3.32M 2022-12
ALKERMES USD 181.42M 15.12M 2022-12
Alnylam Pharmaceuticals USD 89.15M 6.62M 2023-12
Amgen USD 9.52B 4.49B 2023-12
BioMarin Pharmaceutical USD 894.08M 54.62M 2022-12
Dynavax Technologies USD 53.29M 3.88M 2023-12
Exelixis USD 17.32M 7.65M 2023-12
Gilead Sciences USD 3.37B 1.7B 2023-12
Halozyme Therapeutics USD 127.6M 1.32M 2023-12
Incyte USD 62.97M 5.77M 2023-12
Intra Cellular Therapies USD 42.99M 0 2023-12
Ionis Pharmaceuticals USD 28.42M 2.79M 2023-12
Neurocrine Biosciences USD 28.8M 2.9M 2023-09
Pfizer USD 8.98B 532M 2022-12
Regeneron Pharmaceuticals USD 2.58B 18.5M 2023-12
Repligen USD 211.37M 29.5M 2023-09
Sarepta Therapeutics USD 244.01M 17.13M 2023-09
Teva Pharmaceutical Industries USD 3.83B 26M 2022-12
Ultragenyx Pharmaceutical USD 31.8M 3.55M 2023-09
Vertex Pharmaceuticals USD 738.8M 50.1M 2023-12



Neurocrine Biosciences 株式 - 現在の値は、過去のデータ、予測、統計、チャートや経済カレンダー - Apr 2024.